Full Text View
Tabular View
No Study Results Posted
Related Studies
Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
This study is currently recruiting participants.
Verified April 2013 by Memorial Sloan-Kettering Cancer Center
Study NCT01016769   Information provided by Memorial Sloan-Kettering Cancer Center

First Received on November 18, 2009.   Last Updated on April 24, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Squamous Cell Cancer
Head and Neck Cancer
Additional conditions recognized in this trial
Carcinoma, Squamous Cell
Head and Neck Neoplasms
Neoplasms, Squamous Cell
More general conditions related to this trial
Carcinoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Additional drug interventions recognized in this trial
Carboplatin
Everolimus
Paclitaxel
Sirolimus
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Memorial Sloan-Kettering Cancer Center
NATL COMP CA NETWORK
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services